These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36735478)
1. Hepatic steatosis after liver transplantation: a systematic review and meta-analysis. Silva AC; Nogueira P; Machado MV Liver Transpl; 2023 Apr; 29(4):431-448. PubMed ID: 36735478 [TBL] [Abstract][Full Text] [Related]
2. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis. Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032 [TBL] [Abstract][Full Text] [Related]
3. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189 [TBL] [Abstract][Full Text] [Related]
4. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874 [TBL] [Abstract][Full Text] [Related]
5. New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation. Andrade AR; Bittencourt PL; Codes L; Evangelista MA; Castro AO; Sorte NB; Almeida CG; Bastos JA; Cotrim HP Ann Hepatol; 2017 November-December,; 16(6):932-940. PubMed ID: 29055928 [TBL] [Abstract][Full Text] [Related]
7. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607 [TBL] [Abstract][Full Text] [Related]
8. High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter. Mak LY; Chan AC; Wong TC; Dai WC; She WH; Ma KW; Sin SL; Chu KW; Seto WK; Yuen MF; Lo CM; Fung J BMC Gastroenterol; 2023 Sep; 23(1):307. PubMed ID: 37700227 [TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times. Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778 [TBL] [Abstract][Full Text] [Related]
11. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation. Miyaaki H; Miuma S; Taura N; Shibata H; Sasaki R; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K Transplantation; 2019 Jan; 103(1):109-112. PubMed ID: 29894414 [TBL] [Abstract][Full Text] [Related]
13. Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients. Losurdo G; Castellaneta A; Rendina M; Carparelli S; Leandro G; Di Leo A Aliment Pharmacol Ther; 2018 Mar; 47(6):704-714. PubMed ID: 29359341 [TBL] [Abstract][Full Text] [Related]
14. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. Kalogirou MS; Giouleme O World J Transplant; 2022 Sep; 12(9):281-287. PubMed ID: 36187880 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of steatosis after liver transplantation and patient outcomes. Hejlova I; Honsova E; Sticova E; Lanska V; Hucl T; Spicak J; Jirsa M; Trunecka P Liver Transpl; 2016 May; 22(5):644-55. PubMed ID: 26707008 [TBL] [Abstract][Full Text] [Related]
16. De novo metabolic syndrome after liver transplantation: a meta-analysis on cumulative incidence, risk factors, and outcomes. Lim WH; Tan C; Xiao J; Tan DJH; Ng CH; Yong JN; Fu C; Chan KE; Zeng RW; Ren YP; Goh XL; Chew N; Tseng M; Syn N; Mak LY; Fung J; Muthiah M; Siddiqui MS; Tan EXX Liver Transpl; 2023 Apr; 29(4):413-421. PubMed ID: 36724882 [TBL] [Abstract][Full Text] [Related]
17. Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver Cirrhosis. Lim WH; Ng CH; Tan DJH; Xiao J; Fu CE; Ong C; Koh B; Chung C; Tan SN; Wong ZY; Mitchell K; Joseph AA; Tseng M; Syn N; Mak LY; Fung J; Huang DQ; Muthiah M; Tan EXX; Siddiqui MS Transplantation; 2024 Feb; 108(2):473-482. PubMed ID: 37439778 [TBL] [Abstract][Full Text] [Related]
18. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981 [TBL] [Abstract][Full Text] [Related]